40 /100
MEDIUM RISK
Score updated May 30, 2026

KTTA — Pasithea Therapeutics Corp. Dilution Risk Tracker

Track KTTA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KTTA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
37
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.75 below $1 exchange minimum
🔔 Track KTTA — Get forecast alerts →

💹 Market Data

Market Cap$23.90M
Shares Outstanding33.41M
Float18.68M
Cash$50.40M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

25 institutional holders · 12.89M shares
#1 Squadron Capital Management LLC 2.10M shares
#2 ADAGE CAPITAL PARTNERS GP, L.L.C. 2.10M shares
#3 JANUS HENDERSON GROUP PLC 2.10M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest297.5K
Days to Cover1.0
% of Float1.6%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
8-K 8K EVENT May 04, 2026
3 FORM3 Apr 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track KTTA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KTTA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for KTTA
📊 KTTA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 KTTA Signal Convergence & Dark Pool Activity — StonkWhisper 📄 KTTA Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.